• Onconetix provided a non-interest-bearing bridge facility of up to USD 5 million to Realbotix, its pending acquisition target.
• USD 2.5 million was advanced immediately to fund Realbotix growth and working capital while the all-stock deal progresses.
• Facility is cancelled at closing; closing cash is reduced by principal advanced, further reduced by an additional USD 500,000.
• If the share exchange is terminated, the facility begins accruing interest at 12% per year from the termination date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609140830PRIMZONEFULLFEED9825878) on September 14, 2026, and is solely responsible for the information contained therein.